Zeitschriftenartikel zum Thema „Anti-Saccharomyces cerevisiae antibody“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Machen Sie sich mit Top-50 Zeitschriftenartikel für die Forschung zum Thema "Anti-Saccharomyces cerevisiae antibody" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Sehen Sie die Zeitschriftenartikel für verschiedene Spezialgebieten durch und erstellen Sie Ihre Bibliographie auf korrekte Weise.
Fedrigo, Aiessa, Thelma L. Skare, André Luiz Bortoluzzi und Renato Nisihara. „ASCA (Anti-Saccharomyces cerevisiae Antibody) in Patients With Scleroderma“. JCR: Journal of Clinical Rheumatology 25, Nr. 1 (Januar 2019): 24–27. http://dx.doi.org/10.1097/rhu.0000000000000759.
Der volle Inhalt der QuelleOshitani, Nobuhide. „Anti-Saccharomyces Cerevisiae Antibody and 5-aminosalicylic Acid Treatment“. American Journal of Gastroenterology 99, Nr. 5 (Mai 2004): 955. http://dx.doi.org/10.1111/j.1572-0241.2004.40044.x.
Der volle Inhalt der QuelleTeml, Alexander, und Walter Reinisch. „Anti-Saccharomyces Cerevisiae Antibody and 5-aminosalicylic Acid Treatment: Response“. American Journal of Gastroenterology 99, Nr. 5 (Mai 2004): 956. http://dx.doi.org/10.1111/j.1572-0241.2004.40193.x.
Der volle Inhalt der QuelleOshitani, N., F. Hato, Y. Jinno, Y. Sawa, S. Nakamura, T. Matsumoto, S. Seki, S. Kitagawa und T. Arakawa. „IgG subclasses of anti Saccharomyces cerevisiae antibody in inflammatory bowel disease“. European Journal of Clinical Investigation 31, Nr. 3 (März 2001): 221–25. http://dx.doi.org/10.1046/j.1365-2362.2001.00798.x.
Der volle Inhalt der QuelleFilik, Levent, und Ibrahim Biyikoglu. „Differentiation of Behcet’s disease from inflammatory bowel diseases: Anti-saccharomyces cerevisiae antibody and anti-neutrophilic cytoplasmic antibody“. World Journal of Gastroenterology 14, Nr. 47 (2008): 7271. http://dx.doi.org/10.3748/wjg.14.7271.
Der volle Inhalt der QuelleTandio Saputro, Shania Safera, Khayu Wahyunita, Astutiati Nurhasanah, Yudhi Nugraha, Irvan Faizal, Sabar Pambudi und Andri Pramesyanti Pramono. „Expression of modified enhanced green fluorescent polyarginine protein in Saccharomyces cerevisiae INVSc1“. F1000Research 12 (03.01.2023): 1. http://dx.doi.org/10.12688/f1000research.123181.1.
Der volle Inhalt der QuelleVermeire, Severine, Sofie Joossens, Marc Peeters, Fred Monsuur, Godelieve Marien, Xavier Bossuyt, Peter Groenen, Robert Vlietinck und Paul Rutgeerts. „Comparative study of ASCA (Anti–Saccharomyces cerevisiae antibody) assays in inflammatory bowel disease“. Gastroenterology 120, Nr. 4 (März 2001): 827–33. http://dx.doi.org/10.1053/gast.2001.22546.
Der volle Inhalt der QuelleMakharia, Govind K., Vikas Sachdev, Rajiva Gupta, Suman Lal und R. M. Pandey. „Anti-Saccharomyces cerevisiae Antibody Does Not Differentiate Between Crohn's Disease and Intestinal Tuberculosis“. Digestive Diseases and Sciences 52, Nr. 1 (08.12.2006): 33–39. http://dx.doi.org/10.1007/s10620-006-9527-0.
Der volle Inhalt der QuelleChoi, Chang Hwan, Tae Il Kim, Byung Chang Kim, Sung Jae Shin, Sang Kil Lee, Won Ho Kim und Hyon Suk Kim. „Anti-Saccharomyces cerevisiae Antibody in Intestinal Behçetʼs Disease Patients: Relation to Clinical Course“. Diseases of the Colon & Rectum 49, Nr. 12 (Dezember 2006): 1849–59. http://dx.doi.org/10.1007/s10350-006-0706-z.
Der volle Inhalt der QuelleBelazi, Maria, Alexandra Fleva, Drakoulis Drakoulakos und Despina Panayiotidou. „Comparison of salivary IgA and systemic IgA and IgG antibodies to Saccharomyces cerevisiae in HIV-infected subjects“. International Journal of STD & AIDS 14, Nr. 7 (01.07.2003): 458–62. http://dx.doi.org/10.1258/095646203322025759.
Der volle Inhalt der QuelleGriffiths, Anne M., und Mary Zachos. „Antineutrophil Cytoplasmic Antibodies and Anti-Saccharomyces cerevisiae Antibody: Clinical Tools or Clues for Research?“ Journal of Pediatric Gastroenterology and Nutrition 30, Nr. 1 (Januar 2000): 1. http://dx.doi.org/10.1097/00005176-200001000-00006.
Der volle Inhalt der QuelleStandaert–Vitse, Annie, Thierry Jouault, Peggy Vandewalle, Céline Mille, Mimouna Seddik, Boualem Sendid, Jean–Maurice Mallet, Jean–Frédéric Colombel und Daniel Poulain. „Candida albicans Is an Immunogen for Anti–Saccharomyces cerevisiae Antibody Markers of Crohn’s Disease“. Gastroenterology 130, Nr. 6 (Mai 2006): 1764–75. http://dx.doi.org/10.1053/j.gastro.2006.02.009.
Der volle Inhalt der QuelleVermeulen, N., S. Vermeire, P. Rutgeerts und X. Bossuyt. „Likelihood ratio for Crohnʼs disease as a function of Anti-Saccharomyces cerevisiae antibody concentration“. Inflammatory Bowel Diseases 16, Nr. 1 (Januar 2010): 5–6. http://dx.doi.org/10.1002/ibd.20905.
Der volle Inhalt der QuelleAshorn, Sara, Hanna Raukola, Tuuli Välineva, Merja Ashorn, Bo Wei, Jonathan Braun, Immo Rantala et al. „Elevated Serum Anti-Saccharomyces cerevisiae, Anti-I2 and Anti-OmpW Antibody Levels in Patients with Suspicion of Celiac Disease“. Journal of Clinical Immunology 28, Nr. 5 (22.05.2008): 486–94. http://dx.doi.org/10.1007/s10875-008-9200-9.
Der volle Inhalt der QuelleGorgel, Ahmet, Cem Cankaya und Mehmet Tecellioglu. „Anti-Saccharomyces Cerevisiae as Unusual Antibody in Autoimmune Polyglandular Syndrome Type III: A Case Report“. Endocrine, Metabolic & Immune Disorders - Drug Targets 19, Nr. 1 (03.01.2019): 90–94. http://dx.doi.org/10.2174/1871530318666180817143536.
Der volle Inhalt der QuelleKansal, Shivani, Anthony G. Catto-Smith, Karen Boniface, Sarah Thomas, Donald J. Cameron, Mark Oliver, George Alex, Carl D. Kirkwood und Josef Wagner. „Variation of Gut Mucosal Microbiome With Anti-Saccharomyces cerevisiae Antibody Status in Pediatric Crohn Disease“. Journal of Pediatric Gastroenterology and Nutrition 69, Nr. 6 (Dezember 2019): 696–703. http://dx.doi.org/10.1097/mpg.0000000000002461.
Der volle Inhalt der QuelleKirschner, Barbara S., Barbara S. Reid, Ranjana Gokhale und John Hart. „Chronic granulomatous disease (CGD) — another cause of anti-saccharomyces cerevisiae antibody (ASCA) positivty in children“. Gastroenterology 118, Nr. 4 (April 2000): A104. http://dx.doi.org/10.1016/s0016-5085(00)82495-6.
Der volle Inhalt der QuelleMusleh, Mustafa, Drew Triplett und Salma Akram. „Sa1186 Prognostic Significance of Anti-Saccharomyces Cerevisiae Antibody (ASCA) in Southwestern Ohio Veteran IBD Population“. Gastroenterology 148, Nr. 4 (April 2015): S—251. http://dx.doi.org/10.1016/s0016-5085(15)30826-x.
Der volle Inhalt der QuelleNeff, M. W., und D. J. Burke. „Random segregation of chromatids at mitosis in Saccharomyces cerevisiae.“ Genetics 127, Nr. 3 (01.03.1991): 463–73. http://dx.doi.org/10.1093/genetics/127.3.463.
Der volle Inhalt der QuelleHu, Chaojun, Chuiwen Deng, Shulan Zhang, Guang Song, Lijun Li, Xi Li, Li Wang, Fengchun Zhang und Yongzhe Li. „Clinical significance and prevalence of anti-Saccharomyces cerevisiae antibody in Chinese patients with primary biliary cirrhosis“. Clinical and Experimental Medicine 13, Nr. 4 (15.09.2012): 245–50. http://dx.doi.org/10.1007/s10238-012-0207-4.
Der volle Inhalt der QuelleGriffiths, Anne M., Mary Zachos, Philip M. Sherman und Hans Büller. „Antineutrophil Cytoplasmic Antibodies and Anti‐Saccharomyces cerevisiae Antibody: Clinical Tools or Clues for Research?“ Journal of Pediatric Gastroenterology and Nutrition 30, Nr. 1 (Januar 2000): 1. http://dx.doi.org/10.1002/j.1536-4801.2000.tb02648.x.
Der volle Inhalt der QuelleForcione, D. G. „Anti-Saccharomyces cerevisiae antibody (ASCA) positivity is associated with increased risk for early surgery in Crohn's disease“. Gut 53, Nr. 8 (01.08.2004): 1117–22. http://dx.doi.org/10.1136/gut.2003.030734.
Der volle Inhalt der QuelleKim, You Sun, Young-Ho Kim, Byong Duk Ye, Dong Won Park, Ji Won Kim und Dong Soo Han. „Mannose-binding lectin deficiency is not associated with Anti-Saccharomyces cerevisiae antibody in Korean Crohn's disease patients“. Clinica Chimica Acta 429 (Februar 2014): 206–11. http://dx.doi.org/10.1016/j.cca.2013.12.019.
Der volle Inhalt der QuelleBrockerhoff, S. E., und T. N. Davis. „Calmodulin concentrates at regions of cell growth in Saccharomyces cerevisiae.“ Journal of Cell Biology 118, Nr. 3 (01.08.1992): 619–29. http://dx.doi.org/10.1083/jcb.118.3.619.
Der volle Inhalt der QuelleTodorov, I. T., R. Pepperkok, R. N. Philipova, S. E. Kearsey, W. Ansorge und D. Werner. „A human nuclear protein with sequence homology to a family of early S phase proteins is required for entry into S phase and for cell division“. Journal of Cell Science 107, Nr. 1 (01.01.1994): 253–65. http://dx.doi.org/10.1242/jcs.107.1.253.
Der volle Inhalt der QuelleFerreira, Sofia, Ana F. Raimundo, Inês Farrim und Regina Menezes. „Ablation of Kex2 activity enhances proIAPP proteotoxicity in yeast“. Journal Biomedical and Biopharmaceutical Research 19, Nr. 2 (2022): 337–54. http://dx.doi.org/10.19277/bbr.19.2.301.
Der volle Inhalt der QuelleKim, You Sun, Beom Jin Kim, Young-Ho Kim, Won Ho Kim, Joo Sung Kim, Young-Sook Park, Suk-Kyun Yang et al. „T1284 Anti-Saccharomyces Cerevisiae Antibody (ASCA) is a Useful Diagnostic Tool to Differentiate Crohn's Disease From Intestinal Tuberculosis“. Gastroenterology 138, Nr. 5 (Mai 2010): S—528. http://dx.doi.org/10.1016/s0016-5085(10)62438-9.
Der volle Inhalt der QuelleKim, Y. S., Y. H. Kim, B. D. Ye, J. W. Kim und D. S. Han. „P195 Mannose-binding lectin deficiency is not associated with anti-Saccharomyces cerevisiae antibody in Korean Crohn's disease patients“. Journal of Crohn's and Colitis 7 (Februar 2013): S87. http://dx.doi.org/10.1016/s1873-9946(13)60217-2.
Der volle Inhalt der QuelleZhou, Guangxi, Yang Song, Wenjing Yang, Yanmin Guo, Leilei Fang, Yamei Chen und Zhanju Liu. „ASCA, ANCA, ALCA and Many More: Are They Useful in the Diagnosis of Inflammatory Bowel Disease?“ Digestive Diseases 34, Nr. 1-2 (2016): 90–97. http://dx.doi.org/10.1159/000442934.
Der volle Inhalt der QuelleBenmerah, A., J. Gagnon, B. Bègue, B. Mégarbané, A. Dautry-Varsat und N. Cerf-Bensussan. „The tyrosine kinase substrate eps15 is constitutively associated with the plasma membrane adaptor AP-2.“ Journal of Cell Biology 131, Nr. 6 (15.12.1995): 1831–38. http://dx.doi.org/10.1083/jcb.131.6.1831.
Der volle Inhalt der QuelleSherwood, Roy A. „Faecal markers of gastrointestinal inflammation“. Journal of Clinical Pathology 65, Nr. 11 (19.07.2012): 981–85. http://dx.doi.org/10.1136/jclinpath-2012-200901.
Der volle Inhalt der QuelleSmith, Ben R. K., Ian D. R. Arnott, Hazel E. Drummond, Elaine R. Nimmo und Jack Satsangi. „Disease Location, Anti-Saccharomyces cerevisiae Antibody, and NOD2/CARD15 Genotype Influence the Progression of Disease Behavior in Crohn’s Disease“. Inflammatory Bowel Diseases 10, Nr. 5 (September 2004): 521–28. http://dx.doi.org/10.1097/00054725-200409000-00005.
Der volle Inhalt der QuelleCao, Liang, Che-man Chan, Cindy Lee, Samson Sai-yin Wong und Kwok-yung Yuen. „MP1 Encodes an Abundant and Highly Antigenic Cell Wall Mannoprotein in the Pathogenic Fungus Penicillium marneffei“. Infection and Immunity 66, Nr. 3 (01.03.1998): 966–73. http://dx.doi.org/10.1128/iai.66.3.966-973.1998.
Der volle Inhalt der QuelleYorulmaz, Elif, Gupse Adalı, Hatice Yorulmaz, Güralp Taşan, Seval Gürses, Mehmet Ramazan Ayaş und İlyas Tuncer. „The Correlation between New Serological Markers and Disease Phenotype and Activation in Inflammatory Bowel Disease“. Middle East Journal of Digestive Diseases 14, Nr. 3 (30.07.2022): 294–303. http://dx.doi.org/10.34172/mejdd.2022.286.
Der volle Inhalt der QuelleLu, C. F., R. C. Montijn, J. L. Brown, F. Klis, J. Kurjan, H. Bussey und P. N. Lipke. „Glycosyl phosphatidylinositol-dependent cross-linking of alpha-agglutinin and beta 1,6-glucan in the Saccharomyces cerevisiae cell wall.“ Journal of Cell Biology 128, Nr. 3 (01.02.1995): 333–40. http://dx.doi.org/10.1083/jcb.128.3.333.
Der volle Inhalt der QuelleGrabińska, Kariona A., Paula Magnelli und Phillips W. Robbins. „Prenylation of Saccharomyces cerevisiae Chs4p Affects Chitin Synthase III Activity and Chitin Chain Length“. Eukaryotic Cell 6, Nr. 2 (01.12.2006): 328–36. http://dx.doi.org/10.1128/ec.00203-06.
Der volle Inhalt der QuelleGross, Sascha, Sjoerd F. Bakker, Adriaan A. Van Bodegraven, Ingrid M. W. Van Hoogstraten, Kyra A. Gelderman, Gerd Bouma, Chris J. Mulder, B. Mary E. Von Blomberg und Hetty J. Bontkes. „Increased IgA Glycoprotein-2 Specic Antibody Titres in Refractory Celiac Disease“. Journal of Gastrointestinal and Liver Diseases 23, Nr. 2 (01.06.2014): 127–33. http://dx.doi.org/10.15403/jgld.2014.1121.232.sg1.
Der volle Inhalt der QuelleKurokawa, Tomoyo, Chunyeon Lee, Naofumi Shiomi, Atsushi Nakano und Shigeo Katoh. „Secretion of α-Amylase from Saccharomyces cerevisiae and Pichia pastoris and Characterization of Its C-Terminus with an Anti-Peptide Antibody“. JOURNAL OF CHEMICAL ENGINEERING OF JAPAN 35, Nr. 12 (2002): 1277–81. http://dx.doi.org/10.1252/jcej.35.1277.
Der volle Inhalt der QuelleYang, Huiying, Kent D. Taylor, Ying-Chao Lin, Stephan R. Targan und Jerome I. Rotter. „Magnitude of anti-saccharomyces cerevisiae antibody (ASCA) expression is linked, in crohn's disease, families to the major histocompatibility complex (MHC) region“. Gastroenterology 118, Nr. 4 (April 2000): A339. http://dx.doi.org/10.1016/s0016-5085(00)83453-8.
Der volle Inhalt der QuelleTaylor, KD, Z. Li, M. Barry, N. Fischel-Ghodsian, SE Plevy, JI Rotter, SR Targan und H. Yang. „Tumor necrosis factor microsatellite haplotype A11B4C1D3E3 is associated with anti-Saccharomyces cerevisiae antibody (ASCA) across clinical forms of inflammatory bowel disease“. Gastroenterology 114 (April 1998): A1098. http://dx.doi.org/10.1016/s0016-5085(98)84463-6.
Der volle Inhalt der QuelleVasseur, Francis, Boualem Sendid, Thierry Jouault, Annie Standaert-Vitse, Laurent Dubuquoy, Nadine Francois, Corinne Gower-Rousseau et al. „Variants of NOD1 and NOD2 genes display opposite associations with familial risk of crohnʼs disease and anti-saccharomyces cerevisiae antibody levels“. Inflammatory Bowel Diseases 18, Nr. 3 (März 2012): 430–38. http://dx.doi.org/10.1002/ibd.21817.
Der volle Inhalt der QuelleChen, Qingquan, Shirong Huang, Yue Wu, Shuyu Zhang, Qicai Liu und Min Chen. „Age and Gender: Affecting the Positive Rates of Serum PAB and ANCA in Patients with Inflammatory Bowel Disease“. Gastroenterology Research and Practice 2021 (04.08.2021): 1–6. http://dx.doi.org/10.1155/2021/4963641.
Der volle Inhalt der QuelleKaila, Brinderjit, Kenneth Orr und Charles N. Bernstein. „The Anti-Saccharomyces Cerevisiae Antibody Assay in a Province-Wide Practice: Accurate in Identifying Cases of Crohn’s Disease and Predicting Inflammatory Disease“. Canadian Journal of Gastroenterology 19, Nr. 12 (2005): 717–21. http://dx.doi.org/10.1155/2005/147681.
Der volle Inhalt der QuelleKim, B. C., S. Park, J. Han, J. H. Kim, T. I. Kim und W. H. Kim. „Clinical significance of anti-Saccharomyces cerevisiae antibody (ASCA) in Korean patients with Crohn's disease and its relationship to the disease clinical course“. Digestive and Liver Disease 39, Nr. 7 (Juli 2007): 610–16. http://dx.doi.org/10.1016/j.dld.2007.03.006.
Der volle Inhalt der QuelleLevendoglu, Hulya. „Idiopathic Ulcerations of the Esophagus (IUE) in HIV Infection with Positive Anti-Saccharomyces Cerevisiae Antibody (ASCA); Coincidence or Causation, a Case Report“. American Journal of Gastroenterology 101 (September 2006): S325. http://dx.doi.org/10.14309/00000434-200609001-00807.
Der volle Inhalt der QuelleKim, You Sun, Young-Ho Kim, Won Ho Kim, Joo Sung Kim, Young Sook Park, Suk-Kyun Yang, Byong Duk Ye et al. „Diagnostic utility of anti-Saccharomyces cerevisiae antibody (ASCA) and Interferon-γ assay in the differential diagnosis of Crohn's disease and intestinal tuberculosis“. Clinica Chimica Acta 412, Nr. 17-18 (August 2011): 1527–32. http://dx.doi.org/10.1016/j.cca.2011.04.029.
Der volle Inhalt der QuelleVojdani, Aristo. „Elevated IgG Antibody to Aluminum Bound to Human Serum Albumin in Patients with Crohn’s, Celiac and Alzheimer’s Disease“. Toxics 9, Nr. 9 (04.09.2021): 212. http://dx.doi.org/10.3390/toxics9090212.
Der volle Inhalt der QuelleGencheva, Marieta, Mitsuo Kato, Alain N. S. Newo und Ren-Jang Lin. „Contribution of DEAH-box protein DHX16 in human pre-mRNA splicing“. Biochemical Journal 429, Nr. 1 (14.06.2010): 25–32. http://dx.doi.org/10.1042/bj20100266.
Der volle Inhalt der QuelleDowhanick, T. M., S. W. Scherer, G. Willick, I. Russell, G. G. Stewart und V. L. Seligy. „Differential glucoamylase expression in Schwanniomyces castellii induced by maltose“. Canadian Journal of Microbiology 34, Nr. 3 (01.03.1988): 262–70. http://dx.doi.org/10.1139/m88-048.
Der volle Inhalt der QuelleSendid, Boualem, Nicolas Salvetat, Helène Sarter, Severine Loridant, Catherine Cunisse, Nadine François, Rachid Aijjou et al. „A Pilot Clinical Study on Post-Operative Recurrence Provides Biological Clues for a Role of Candida Yeasts and Fluconazole in Crohn’s Disease“. Journal of Fungi 7, Nr. 5 (22.04.2021): 324. http://dx.doi.org/10.3390/jof7050324.
Der volle Inhalt der Quelle